First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]

Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige(®)) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wittenberg, Ralf H, Schell, Ernest, Krehan, Gerhard, Maeumbaed, Roland, Runge, Hans, Schlüter, Peter, Fashola, Taiwo OA, Thurston, Helen J, Burger, Klaus J, Trechsel, Ulrich
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1526611/
https://ncbi.nlm.nih.gov/pubmed/16469112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados